Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children

Abstract Background Technetium-99m-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) is recognized as a promising radiopharmaceutical for diagnosing neuroendocrine tumors (NETs). However, 99mTc-HYNIC-TOC dosimetry has been investigated only for adults. As pediatric radionuclide therapies becom...

Full description

Bibliographic Details
Main Authors: Xinchi Hou, Bozena Birkenfeld, Hanna Piwowarska-Bilska, Anna Celler
Format: Article
Language:English
Published: SpringerOpen 2017-10-01
Series:EJNMMI Physics
Subjects:
Pediatric patient-specific dosimetry
99mTc-HYNIC-Tyr3-octreotide
SPECT/CT
Neuroendocrine tumors
Online Access:http://link.springer.com/article/10.1186/s40658-017-0191-6

Internet

http://link.springer.com/article/10.1186/s40658-017-0191-6

Similar Items